Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 313

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

The future of blood‐based biomarkers for Alzheimer's disease

Open access
Henriksen, Kim, O'Bryant, Sid E., Hampel, Harald, Trojanowski, John Q., Montine, Thomas J., Jeromin, Andreas, Blennow, Kaj, Lönneborg, Anders, Wyss‐Coray, Tony, Soares, Holly, Bazenet, Chantal, Sjögren, Magnus, Hu, William, Lovestone, Simon, Karsdal, Morten A., Weiner, Michael W., Blood‐Based Biomarker Interest Group · 2014 · Alzheimer's & Dementia

Abstract

Treatment of Alzheimer's disease (AD) is significantly hampered by the lack of easily accessible biomarkers that can detect disease presence and predict disease risk reliably. Fluid biomarkers of AD currently provide indications of disease stage; however, they are not robust predictors of disease progression or treatment response, and most are measured in cerebrospinal fluid, which limits their applicability. With these aspects in mind, the aim of this article is to underscore the concerted efforts of the Blood‐Based Biomarker Interest Group, an international working group of experts in the field. The points addressed include: (1) the major challenges in the development of blood‐based biomarkers of AD, including patient heterogeneity, inclusion of the “right” control population, and the blood–brain barrier; (2) the need for a clear definition of the purpose of the individual markers (e.g., prognostic, diagnostic, or monitoring therapeutic efficacy); (3) a critical evaluation of the ongoing biomarker approaches; and (4) highlighting the need for standardization of preanalytical variables and analytical methodologies used by the field.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2013.01.013

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 6

  1. Tanne J.H., 2012, US scientists discuss early detection and treatment of Alzheimer's disease, BMJ, 344, e1068, 10.1136/bmj.e1068 · doi:10.1136/bmj.e1068
  2. Llano D.A., 2012, Alzheimer Dis Assoc Disord
  3. 10.1007/s12031-010-9403-4 · doi:10.1007/s12031-010-9403-4
  4. Neselius S., 2012, Brain Injury
  5. 10.1016/j.joca.2005.05.004 · doi:10.1016/j.joca.2005.05.004
  6. U.S. Food and Drug Administration, 2001, Guidance for industry: bioanalytical method validation

Cited by

See all 313

Metadata

Authors
Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H., Bazenet, C., Sjögren, M., Hu, W., Lovestone, S., Karsdal, M. A., Weiner, M. W., & Blood‐Based Biomarker Interest Group
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2013-07-15
Volume
10
Issue
1
Pages
115-131
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1968790254
Cited by
313
References
141
FWCI
17.65
Type
journal article
Language
en
Open access
green
Funders
  • Vetenskapsrådet (14002)
  • National Institutes of Health
  • National Institute on Aging (R01AG039389)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.